Drug Profile
Clarithromycin oral - Gardant
Alternative Names: BIO 207Latest Information Update: 29 Dec 2021
Price :
$50
*
At a glance
- Originator Gardant Pharmaceuticals
- Class Antibacterials; Macrolides
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 04 Jan 2007 Gardant Pharmaceuticals has been acquired by Switch Pharma
- 21 Oct 2005 Phase-II clinical trials in Bacterial infections in USA (PO)